Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2023 - Livestream (virtual)

November 10, 2023 to November 11, 2023

Course Directors: Tanios S. Bekaii-Saab, M.D., Mitesh J. Borad, M.D., Sean P. Cleary, M.D., and G. Dan Duda, D.M.D., Ph.D.

November 10 - 11, 2023 - Internet Live Activity - Las Vegas, Nevada

In collaboration with the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO)

The 2023 Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium will provide a multidisciplinary overview on the importance of early diagnosis and treatment considerations, including surgery, radiation, loco-regional approaches, and systemic therapies. Nationally and internationally renowned faculty will offer state-of-the-art updates on current treatment options for patients with hepato-pancreatico-biliary cancers. This timely education will be delivered through case-based discussions, interactive Q&A, and didactic presentations. Target audience for this activity includes physicians and allied health professionals.

Registration Fee                             


MD, DO, PhD

$610


Allied Health, NP, PA, RN,
Fellows, Residents, Retired

$485

Target Audience

This course is intended for surgeons, gastroenterologists, medical and radiation oncologists, laboratory scientists, and allied health professionals in the following specialties: medical oncology, hematology, gastroenterology, radiation oncology, surgical oncology, pathology, radiology, and laboratory research science.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe innovative options for patients with pancreas, liver and biliary cancers with limited oligometastatic disease.
  • Identify current and emerging strategies for early diagnosis of liver cancer.
  • Identify patients suitable for a liver transplantation, surgical resection, radiation therapy, or other loco-regional approaches.
  • Integrate novel molecularly-targeted strategies in clinical trial participation.
  • Recognize the appropriate regimen for first and second line therapy in treating advanced pancreatic cancer, liver and biliary cancer.
  • Describe the latest state of the science in pancreatic cancer, liver and biliary cancer.


Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Course summary
Available credit: 
  • 8.75 ABS
  • 8.75 AMA PRA Category 1 Credit™
  • 8.75 Attendance
Event starts: 
11/10/2023 - 8:00am
Event ends: 
11/11/2023 - 1:00pm
Cost:
$610.00
Part of: 
Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2023

 

Click here to view Program Schedule on mobile

 
Internet Live Activity
Las Vegas, NV 89109
United States

All travel and lodging expenses are the sole responsibility of the individual registrant.

Course Directors

Tanios S. Bekaii-Saab, M.D.
Professor of Medicine, Mayo Clinic College of Medicine and Science
Mayo Clinic
Phoenix, Arizona

Mitesh J. Borad, M.D.
Professor of Medicine, Mayo Clinic College of Medicine and Science
Mayo Clinic
Phoenix, Arizona

Sean P. Cleary, M.D.
Professor of Surgery, Mayo Clinic College of Medicine and Science
Division Chair, Hepatobiliary/Pancreatic Surgery
Mayo Clinic
Rochester, Minnesota

G. Dan Duda, DMD, PhD, FAIMBE, FAAAS
Director of Translational Research in GI Radiation Oncology,
Massachusetts General Hospital
Investigator, Edwin L. Steele Laboratories for Tumor Biology,
Massachusetts General Hospital Research Institute
Associate Professor of Tumor Biology, Harvard Medical School
Massachusetts General Hospital
Boston, Massachusetts

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 8.75 ABS
  • 8.75 AMA PRA Category 1 Credit™
  • 8.75 Attendance

For information regarding exhibit opportunities, please reach out to Kristy Badder.

Price

Cost:
$610.00
Please login or register to take this course.

To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity.  This course is not approved for on-demand delivery.

Commitment to Equity, Diversity and Inclusion​ 

Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.  ​ 

Cancellation and Refund Policy

View Cancellation and Refund Policy

All requests must be submitted in writing using the Contact Us Form.

Any use of this site constitutes your agreement to the Terms and Conditions of Registration.